Tyrosinaemia screening implemented in England
Tyrosinaemia screening implemented in England
Newborn screening for hereditary tyrosinaemia type 1 (HT1) has been implemented in England.
Newborn screening for hereditary tyrosinaemia type 1 (HT1) has been implemented in England.
The fetal, maternal and child health (FMCH) group and adult reference group (ARG) of the UK NSC are looking for new members.
The 2021 UK National Screening Committee call for new screening ‘topics’ (conditions) opens.
The 2021 annual call is your opportunity to make a proposal for a new screening topic to be considered by the UK National Screening Committee as part of its regular review process.
A review of the use of artificial intelligence (AI) in breast cancer screening, commissioned by the UK National Screening Committee (UK NSC), has found that humans are still better than technology at spotting possible cases of breast cancer during screening.
Find out more about the 12 current vacancies for UK National Screening Committee members.
To mark the committee’s 25th anniversary, Dr Angela Raffle explains how the UK NSC has helped transform screening for the better from the ‘bad old days’ of haphazard, ineffective and harmful activities.
The UK National Screening Committee is celebrating its 25th anniversary. Dr Angela Raffle looks back at its creation and how it has transformed screening for the better.
Details of the public dialogue, commissioned by the UK NSC, Genomics England and the UKRI's Sciencewise programme, to understand the views of the public about the potential use of whole genome sequencing in newborn screening.
In the first in a series of profiles of UK NSC members, we hear from the chair, Professor Bob Steele.
How much do you know about the UK National Screening Committee?